| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00445055 Details | 2011-12-13 Interventional | 4 | 71 | Droperidol Nausea Postoperative N… Vomiting | - - | |||
| NCT00554775 2006-000113-38 Details | 2011-12-12 Interventional | 2 | 80 | Erlotinib Hydro… Brain Neoplasms Lung Neoplasms Lung Cancer Metastatic Canc… | IDMC made a recommendation to stop the trial as the target for continuing to the 2nd phase was
not met. - | |||
| NCT00565656 Details | 2011-12-08 Interventional | 2 | - | Bevacizumab Myelodysplastic… Preleukemia Syndrome | - - | |||
| NCT00456482 Details | 2011-12-08 Interventional | 2/3 | 239 | Fluocinolone Ac… Uveitis Non-infectious … | SARS epidemic in Asia and Canada - | |||
| NCT00460551 Details | 2011-12-06 Interventional | 2 | 13 | Zalutumumab Carcinoma, Non-… Lung Neoplasms Non Small Cell … | Due to considerations regarding the appropriate therapeutic regimen for these patients. The trial was prematurely closed. The original protocol contained Part 1A, followed by Part 1B and Part 2. The trial was terminated when 13 patients were enrolled in Part 1A. Scans for efficacy were planned for Part 1B and Part 2. | |||
| NCT01029795 Details | 2011-12-02 Interventional | 2 | 38 | Glyburide Diabetes Mellit… Diabetes Mellit… | Terminated due to nonclinical safety findings Since Study GMAJ was terminated after enrolling only 38 participants with just 1 participant completing 12 weeks of treatment, only disposition, demographics, and safety data are reported. | |||
| NCT00593008 Details | 2011-12-02 Interventional | 1 | 5 | Gemcitabine MTOR Inhibitors Sirolimus Temsirolimus Pancreatic Neop… Pancreatic Aden… | - - | |||
| NCT01204853 Details | 2011-12-01 Interventional | 3 | 2 | Sitaxsentan Hypertension Hypertension, P… Pulmonary Arter… | Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns,
specifically new emerging evidence of hepatic injury. - | |||
| NCT00418574 2006-002801-30 Details | 2011-11-24 Interventional | 2/3 | 888 | Abagovomab Carcinoma, Ovar… Ovarian Neoplas… Ovarian Cancer | No benefit on primary end point (RFS); no rationale to collect survival data - | |||
| NCT00400764 Details | 2011-11-23 Interventional | 1/2 | 72 | Rituximab Lymphoma Lymphoma, Non-H… Non-Hodgkin's L… | - The Sponsor terminated the study on 5 May 2010, prior to the completion of the 36-month follow-up (FU) period, based on the primary analysis results. All patients were off-study or in survival FU (the treatment period was completed). | |||
| NCT01473069 Details | 2011-11-21 Interventional | 1 | 41 | Ketoconazole Healthy | - - | |||
| NCT01014481 Details | 2011-11-17 Interventional | 4 | 156 | Efavirenz Lamivudine Tenofovir Tuberculosis HIV Infections | this study was ended prematurely by ethical committees with a reason of the final outcome was
achieved with no longer recruitment was needed. - | |||
| NCT01165970 2008-005451-23 2008-005451-23 Details | 2011-11-15 Interventional | 2/3 | 19 | Carboxymethylce… Xerostomia Hyposalivation | - - | |||
| NCT00169221 Details | 2011-11-15 Interventional | 2 | 54 | Gefitinib Head and Neck N… Head and Neck C… | Toxicity in an independent study IMEX. The trial was subsequently terminated (54 pts instead of
140) despite safety analyses showing no excess of toxicity - | |||
| NCT01029223 Details | 2011-11-09 Interventional | 4 | - | Metoprolol Blood Pressure | - - | |||
| NCT00957346 Details | 2011-11-08 Interventional | 3 | - | Mifepristone Misoprostol Abortion, Induc… | - - | |||
| NCT00171600 Details | 2011-11-08 Interventional | 4 | 54 | Lisinopril Valsartan Diabetic Nephro… Kidney Diseases Early Diabetic … Hypertension | - - | |||
| NCT00111306 2005-000705-59 Details | 2011-11-08 Interventional | 3 | - | Epratuzumab Lupus Erythemat… Systemic Lupus … | - - | |||
| NCT00083993 Details | 2011-11-08 Interventional | 3 | - | Letrozole MTOR Inhibitors Sirolimus Temsirolimus Breast Neoplasm… Neoplasm Metast… Neoplasms | - - | |||
| NCT00918931 Details | 2011-11-04 Interventional | 2 | 3 | Obatoclax Mastocytosis Mastocytosis, S… Leukemia Systemic Mastoc… | - - |